Navigation Links
Abbott 'Goes Red' to Educate Bay Area Women About Heart Disease
Date:2/1/2008

Abbott Sponsors American Heart Association's 'Go Red for Women' Movement in

the Bay Area

SANTA CLARA, Calif., Feb. 1 /PRNewswire/ -- As a leader in cardiovascular treatment and the exclusive Bay Area "hometown" partner for the national "Go Red for Women" program, Abbott (http://www.abbott.com) is partnering with the American Heart Association (AHA) to raise awareness about heart disease, the leading cause of death for women in America.

One out of every three American women will die of heart disease, yet, according to AHA, only 13 percent of women believe heart disease is their greatest health risk. While largely preventable, heart disease in women often goes underdiagnosed and undertreated. Data shows that most women fail to make the connection between risk factors like high blood pressure and high cholesterol and their risk of developing heart disease.

Through this year-long campaign, which kicks off in February -- American Heart Month -- Abbott and AHA hope to raise awareness that even women without classic risk factors and symptoms may be at risk -- just ask Michelle Smietana, a software testing engineer at Abbott. Ironically, Michelle just had her blood pressure and cholesterol checked -- both were normal. While she used to smoke and had been a bit overweight, she was feeling strong and healthy so she didn't know what to suspect last spring when she experienced some back pain that crept into her neck. At just 33, both she and the cardiologist who treated her were shocked when her ultrasound results showed evidence of a heart attack.

"If heart disease can happen to me, it can happen to anyone. I was only

33, had low cholesterol and good blood pressure. I didn't have the

"normal" symptoms you associate with heart disease like left arm pain and

pressure in my chest. Going through cardiac rehabilitation helped make

exer
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Abbott to Present at Merrill Lynch Healthcare Conference
2. Abbotts Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA
3. Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2007 Earnings
4. Cookie Johnson and Abbott Bring I Stand With Magic: Campaign to End Black AIDS to Los Angeles to Educate African-American Women on HIV/AIDS
5. Ugandan Children Are Among the First to Receive Abbotts Lower-Strength Aluvia (lopinavir/ritonavir) Tablet
6. The Magic Johnson Foundation and Abbott Expand Focus of Campaign to End Black AIDS to African-American Women in 2008
7. FDA Advisory Committee Recommends Approval of Abbotts XIENCE(TM) V Drug Eluting Stent System
8. Abbotts Environmental Protection Initiatives Again Recognized by the State of Illinois
9. Abbott Employees Give Back to Local Communities This Holiday Season
10. AUDIO from Medialink and Abbott Labs: Easing Holiday Stress for Families of Those With Diabetes
11. Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/10/2014)... Major League Baseball players who undergo Tommy John ... they had before surgery, according to a Henry Ford ... show a link between the surgery and declining pitching ... largest cohort of professional pitchers to date to examine ... MLB pitchers before and after surgery between 1982 and ...
(Date:3/10/2014)... ORLEANS─Ulnar collateral ligament (UCLR) reconstruction, otherwise known as "Tommy ... League Baseball (MLB) pitchers with a damaged or torn ... overuse. , In the new study, "Rate ... Surgery in Major League Baseball Pitchers," * presented today ... of Orthopaedic Surgeons (AAOS), researchers looked at the rate ...
(Date:3/10/2014)... senior athletes are high functioning despite having one ... onset osteoarthritis (OA): developmental dislocation of the ... impingement (FAI), a condition in which the hip ... presented today at the 2014 Annual Meeting of ... In the study, "Prevalence of Radiographic Abnormalities in ...
(Date:3/10/2014)... CAPE TOWN, ZA, March 11, 2014 Aeras today ... (TB) vaccine trial designed to study prevention of ... II study of the TB vaccine candidate, H4+IC31 (AERAS-404), ... infection by Mtb, the bacterium that causes TB. The ... also evaluate BCG revaccination. , This novel trial ...
(Date:3/10/2014)... Some sour news for lactose-intolerant people who hoped that ... milk: A pilot study from the Stanford University School ... two. , The study was small it involved ... results were highly consistent among all the participants and ... milk. , "It,s not that there was a trend ...
Breaking Medicine News(10 mins):Health News:Study: MLB pitchers don't regain performance level after Tommy John surgery 2Health News:Study: MLB pitchers don't regain performance level after Tommy John surgery 3Health News:Novel vaccine trial design aims to answer key TB questions 2Health News:Novel vaccine trial design aims to answer key TB questions 3Health News:Claim that raw milk reduces lactose intolerance doesn't pass smell test, study finds 2Health News:Claim that raw milk reduces lactose intolerance doesn't pass smell test, study finds 3Health News:Claim that raw milk reduces lactose intolerance doesn't pass smell test, study finds 4
... Accident Fund Insurance,Company of America has recognized ... a safe work environment. The company,recently surpassed 2 ... in 2006 the Michigan construction industry reported more,than ... Clark Construction,received the Gold Award from MIOSHA in ...
... Acknowledges Department,s Anti-Violence,Program, PHILADELPHIA, March 27 ... partners were recognized today by Philadelphia,City Council ... System, or PIRIS, a unique pilot program ... system provides comprehensive intervention services to 15- ...
... Rupp has won the 2008 National Sleep Foundation Young ... young sleep researchers (i.e., within 5 years of having ... Sleep Foundation (NSF). Each submission was rated by a ... abstracts, the top 16 were chosen (8 "clinical research" ...
... Teens Still Feel Targeted By Tobacco Advertising and Find ... Kids across Connecticut,will rally against tobacco on April 2 ... 13th annual Kick Butts Day, sponsored by the,Campaign for ... (for a list of local events, go to, http://www.kickbuttsday.org/events ...
... announced today that it has opened a Center for ... first in the Denver,area, one of many new markets ... Denver Center brings the Company,s total number of Centers,to ... the prevalence rate of,hemorrhoids in the US is about ...
... Bush FY 2009 Budget Slashes Nursing Home Funding ... Cuts Place Greater,Pressure on State Medicaid Program as ... National and state,front line caregivers voiced opposition today ... for Michigan seniors contained in the,Bush Administration,s FY ...
Cached Medicine News:Health News:Accident Fund Recognizes Clark Construction Co. for 2 Million Hours without a Lost-Time Injury 2Health News:Department of Health Highlights Violence as a Public Health Issue 2Health News:Connecticut Kids 'Kick Butts' on April 2 2Health News:Connecticut Kids 'Kick Butts' on April 2 3Health News:CRH Medical Corporation opens new center in Denver, Colorado 2Health News:National, State Front Line Caregivers Warn About $64 Million Cut to Medicare Funding for Care of Michigan Seniors 2Health News:National, State Front Line Caregivers Warn About $64 Million Cut to Medicare Funding for Care of Michigan Seniors 3Health News:National, State Front Line Caregivers Warn About $64 Million Cut to Medicare Funding for Care of Michigan Seniors 4
(Date:1/15/2014)... WORTH, Texas , Jan. 15, 2014  Humberto ... in Dermatology Achievement Award" from the Journal of ... Dermatology Aesthetic & Clinical Conference (ODAC). The event is January ... Florida . The ... report on the practice of dermatology for clinical and ...
(Date:1/15/2014)... 2014 MultiCell Technologies, Inc. (OTC Bulletin Board: ... patent application concerning composition of matter, biological targets, mechanism ... cell death.  This patent application describes ... RNA molecules (VSRNAs) which interfere with the basic homeostatic ... size less than 10 bps, yet are surprisingly capable ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ... the past decade has seen the atopic ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... and ensure faster access to client ... ... DATA ), a technology and services company focused on global,eClinical solutions ... efficiency for end-users with the,DATATRAK eClinical(TM) 2008 Q1 Release., ...
... needle-free vaccine,platform that elicits a robust immune response ... been awarded a U.S. patent. The University of,Michigan ... from the,university, licenses the patent and its associated ... nanoemulsion,technology, have elicited a dramatic immune response in ...
Cached Medicine Technology:DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.0 2DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.0 3DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.0 4DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.0 5New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity 2New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity 3
... CLIA Waived Drug Tests are easy to ... They demonstrate excellent correlation with laboratory GC/MS ... results in minutes instead of days. These ... laboratories in clinics, physician offices and rehabilitation ...
... of abuse tests are highly accurate in detecting ... cut-off as confirmed by GC/MS testing. This assay ... alternative method (such as GC/MS) must be used ... judgment should be applied to any drug of ...
... becomes preservative-free on eye contactits patented ... water on eye contact. It is ... moderate dryness or eyes that need ... can have the benefits of a ...
... to saturate dry eyes, providing the dosing ... For maximum hydration and relief of dryness, ... contents of one container, in both eyes ... least 4 times a day. As your ...
Medicine Products: